Kala Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €103.51M -9.9% -€18.16M +10.0% -17.5% -0.032 pp N/A N/A
    (estimated) €114.91M +∞% -€16.51M -36.5% -14.4% -0.14 pp N/A N/A
    (estimated) N/A -€25.99M -9.7% N/A N/A N/A
    (estimated) €0.00 +NaN% -€28.79M -15.3% N/A N/A N/A
    (estimated) €0.00 +NaN% -€33.99M +3.1% N/A N/A N/A
    €0.00 +NaN% -€32.97M -8.7% N/A -€24.98M +6.8% N/A
    €0.00 -100.0% -€36.13M +18,823.3% N/A -€23.39M -65.2% N/A
    €3.33M -65.4% -€190.91K -99.9% -5.7% +13 pp -€67.28M -26.8% -2,019.4% -11 pp
    €9.62M +76.7% -€130.38M +36.0% -1,354.9% +4.1 pp -€91.90M +21.0% -955.1% +4.4 pp
    €5.45M +4.7% -€95.89M +9.8% -1,760.5% -0.81 pp -€75.98M -2.9% -1,395.0% +1.1 pp
    €5.20M +∞% -€87.31M +52.8% -1,679.0% -17 pp -€78.23M +73.9% -1,504.5% -15 pp
    €0.00 +NaN% -€57.13M +58.1% N/A -€44.98M +56.3% N/A
    €0.00 +NaN% -€36.14M +27.3% N/A -€28.78M +23.6% N/A
    €0.00 -100.0% -€28.39M +98.8% N/A -€23.28M +83.3% N/A
    €38.52K -90.1% -€14.28M -13.8% -37,071.1% -330 pp -€12.70M -2.0% -32,971.1% -300 pp
    €389.52K +810.0% -€16.57M +81.7% -4,255.2% +170 pp -€12.96M +50.6% -3,326.6% +170 pp
    €42.80K -€9.12M -21,306.0% -€8.61M -20,106.0%

    Notifications